Unlike secondary erythrocytosis, the most common form of primary erythrocytosis is the myeloproliferative neoplasm polycythemia vera (PV) characterized by the presence of the JAK2 V617F somatic mutation in approximately 97% of cases and typically a low serum erythropoietin. This evidence concerns the gene JAK2 and acquired polycythemia vera.